What is the appropriate dosing regimen for W‑Biest 50/50 progesterone cream (5 % w/w, 200 mg/mL)?

W-Biest 50/50 Progesterone Cream Dosing

Apply the cream once or twice daily to areas such as inner arms, thighs, chest, or inner forearms, as this is the standard dosing regimen for this compounded bioidentical hormone preparation 1.

Understanding the Formulation

W-Biest 50/50 is a compounded topical cream containing bioidentical estriol and estradiol (in an 80:20 ratio) plus progesterone at 5% w/w concentration (200 mg/mL). This formulation is marketed for menopausal symptom relief 1.

Dosing Considerations

Standard Application Protocol

• Frequency: Apply 1-2 times daily 1
• Application sites: Inner arms, thighs, chest, or inner forearms (rub arms together after application) 1
• Typical dose per application: Approximately 1/4 teaspoon delivers roughly 20-40 mg of progesterone

Evidence on Transdermal Progesterone Absorption

The pharmacokinetic data reveals important considerations:

• Absorption variability: Transdermal progesterone cream (40 mg daily) produces measurable serum progesterone increases, though with wide individual variation 2
• Comparative exposure: OTC progesterone cream at 40 mg twice daily (80 mg total) produces drug exposure comparable to FDA-approved oral progesterone 200 mg 3
• High permeation rates: Studies using Pentravan cream (a common compounding vehicle) show that progesterone has the highest permeation among female sex steroids, with approximately 38.4 mg of a 50 mg dose potentially entering the bloodstream over 48 hours 4

Clinical Context and Caveats

Important Limitations

This is a compounded product without FDA approval for specific therapeutic indications, and the evidence base differs substantially from standardized hormone replacement therapy 1.

Comparison to Evidence-Based HRT

The available guidelines focus on standardized hormone therapy regimens:

• Preferred approach for menopausal symptoms: Transdermal 17β-estradiol patches (50-100 μg daily) combined with micronized progesterone 200 mg orally or vaginally for 12-14 days per 28-day cycle 5
• Progesterone dosing in standard HRT: Sequential regimens require 200 mg of oral or vaginal micronized progesterone for 12-14 days every 28 days for endometrial protection 5

Safety Concerns

• Contraindications: Avoid if pregnant, nursing, or with serious medical conditions 1
• Overdose risk: Given the high permeation rates demonstrated in pharmacokinetic studies, careful attention to the quantity of cream applied is essential to avoid excessive hormone exposure 4
• Lack of standardization: Compounded preparations lack the quality control and consistent dosing of FDA-approved products

Efficacy Questions

While one small study showed transdermal progesterone cream improved vasomotor symptoms in 83% of treated women versus 19% with placebo 6, this same study found no protective effect on bone density, a key outcome for menopausal hormone therapy.

Practical Application Algorithm

1. Start with once-daily application of approximately 1/4 teaspoon
2. Apply to consistent site (inner forearm or thigh preferred for absorption consistency)
3. Monitor symptoms over 2-4 weeks
4. Adjust to twice daily only if inadequate symptom control with once-daily dosing
5. Consider transition to evidence-based standardized HRT if compounded therapy proves inadequate or if endometrial protection is a concern

The lack of robust clinical trial data supporting this specific compounded formulation for defined therapeutic outcomes means patients should be counseled about the superior evidence base for FDA-approved hormone replacement products 5.